Xiangjie Lin

783 total citations
31 papers, 396 citations indexed

About

Xiangjie Lin is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Xiangjie Lin has authored 31 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 14 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Xiangjie Lin's work include Acute Myeloid Leukemia Research (10 papers), Multiple Myeloma Research and Treatments (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Xiangjie Lin is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Multiple Myeloma Research and Treatments (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Xiangjie Lin collaborates with scholars based in China, United States and Australia. Xiangjie Lin's co-authors include Jie Jin, Fenglin Li, Huafeng Wang, Shihui Mao, Wenle Ye, Wenwen Wei, Debasis Patnaik, Gregory D. Cuny, Jiansong Huang and Marcie A. Glicksman and has published in prestigious journals such as Blood, European Journal of Pharmacology and Anesthesia & Analgesia.

In The Last Decade

Xiangjie Lin

30 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangjie Lin China 11 213 70 66 58 58 31 396
Guowei Dai China 9 268 1.3× 68 1.0× 156 2.4× 55 0.9× 17 0.3× 18 451
Frida Schain Sweden 12 124 0.6× 58 0.8× 77 1.2× 34 0.6× 16 0.3× 27 340
Rebecca E. Parker United States 12 179 0.8× 70 1.0× 70 1.1× 25 0.4× 22 0.4× 23 398
Biqin Tan China 13 152 0.7× 46 0.7× 15 0.2× 45 0.8× 37 0.6× 22 347
Debora Valli Italy 12 263 1.2× 92 1.3× 109 1.7× 35 0.6× 11 0.2× 14 417
Yunfeng Shen China 12 111 0.5× 60 0.9× 101 1.5× 96 1.7× 19 0.3× 29 309
Feili Chen China 9 102 0.5× 60 0.9× 39 0.6× 52 0.9× 12 0.2× 19 275
Andrea Clarke United States 8 166 0.8× 73 1.0× 34 0.5× 30 0.5× 16 0.3× 17 368
Xiaoming Zou United States 10 244 1.1× 65 0.9× 68 1.0× 35 0.6× 10 0.2× 12 345
Makoto Hamada Japan 11 114 0.5× 82 1.2× 34 0.5× 22 0.4× 97 1.7× 21 375

Countries citing papers authored by Xiangjie Lin

Since Specialization
Citations

This map shows the geographic impact of Xiangjie Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangjie Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangjie Lin more than expected).

Fields of papers citing papers by Xiangjie Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangjie Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangjie Lin. The network helps show where Xiangjie Lin may publish in the future.

Co-authorship network of co-authors of Xiangjie Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangjie Lin. A scholar is included among the top collaborators of Xiangjie Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangjie Lin. Xiangjie Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Xiangjie, Min Xin, Xia Li, et al.. (2025). α-Actinin-1 deficiency in megakaryocytes causes low platelet count, platelet dysfunction, and mitochondrial impairment. Blood Advances. 9(5). 1185–1201. 2 indexed citations
2.
Huang, Xin, Xiangjie Lin, Xia Li, et al.. (2025). Tryptanthrin impairs platelet function and thrombus formation by reducing Gp1bα expression. European Journal of Pharmacology. 991. 177332–177332. 2 indexed citations
3.
Li, Li, Hong Ma, Jiawen Lin, et al.. (2025). Application and evaluation of virtual simulation technology in ‘corneal contact lens’ education. BMC Medical Education. 25(1). 357–357.
4.
Wei, Jianhe, Xiangjie Lin, Yujie Wang, et al.. (2025). Meibomian gland alterations in allergic conjunctivitis: insights from a novel quantitative analysis algorithm. Frontiers in Cell and Developmental Biology. 12. 1518154–1518154. 5 indexed citations
5.
Lin, Xiangjie, Huafeng Wang, & Jie Jin. (2024). Integrating Spatial Transcriptome, Single-Cell Sequencing and Histopathology Reveals Bone Marrow Spatial Heterogenous in AML Patients. Blood. 144(Supplement 1). 2215–2215. 1 indexed citations
6.
Zhang, Xuemei, Jianhe Wei, Xiangjie Lin, et al.. (2024). An integrative predictive model for orthokeratology lens decentration based on diverse metrics. Frontiers in Medicine. 11. 1490525–1490525. 4 indexed citations
7.
Zhao, Jianhui, Rong Fan, Yuchen Zhang, et al.. (2024). Global, regional, and national burden and quality of care of multiple myeloma, 1990–2019. Journal of Global Health. 14. 4033–4033. 9 indexed citations
8.
Ye, Wenle, Xin Huang, Jiansong Huang, et al.. (2023). Glutamate dehydrogenase 1: A novel metabolic target in inhibiting acute myeloid leukaemia progression. British Journal of Haematology. 202(3). 566–577. 10 indexed citations
9.
Huang, Jiansong, et al.. (2023). Mice Lacking α-Actinin-1 in Megakaryocytes Display the Feature of Thrombocytopenia and Impair Platelet Functions. Blood. 142(Supplement 1). 2576–2576. 1 indexed citations
10.
Mao, Shihui, Qian Yu, Wenwen Wei, et al.. (2023). FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis. Annals of Hematology. 102(3). 583–595. 7 indexed citations
11.
Mao, Shihui, Jiajia Pan, Wenwen Wei, et al.. (2023). CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML. Cancer Biomarkers. 37(3). 133–145. 4 indexed citations
12.
Ye, Wenle, Xin Huang, Xia Li, et al.. (2023). The ferroptosis landscape in acute myeloid leukemia. Aging. 15(22). 13486–13503. 6 indexed citations
13.
Li, Fenglin, Qing Ling, Ying Chen, et al.. (2023). Dihydropyrimidinase‐like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia. Cancer Medicine. 12(7). 8319–8330. 8 indexed citations
14.
Wei, Wenwen, Jiajia Pan, Jinghan Wang, et al.. (2023). circSLC25A13 acts as a ceRNA to regulate AML progression via miR‐616‐3p/ADCY2 axis. Molecular Carcinogenesis. 62(10). 1546–1562. 4 indexed citations
15.
16.
Wei, Wenwen, Shujuan Huang, Qing Ling, et al.. (2022). Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia. Journal of Translational Medicine. 20(1). 299–299. 12 indexed citations
17.
Lin, Xiangjie, Jinghan Wang, Xin Huang, et al.. (2021). Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 study. Aging. 13(7). 10468–10489. 35 indexed citations
18.
Li, Fenglin, Xiang Zhang, Shihui Mao, et al.. (2021). MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway. EBioMedicine. 69. 103441–103441. 10 indexed citations
19.
Huang, Jiansong, Xin Huang, Xia Li, et al.. (2021). Abivertinib inhibits megakaryocyte differentiation and platelet biogenesis. Frontiers of Medicine. 16(3). 416–428. 11 indexed citations
20.
Pejo, Ervin, Jifeng Liu, Xiangjie Lin, & Douglas E. Raines. (2016). Distinct Hypnotic Recoveries After Infusions of Methoxycarbonyl Etomidate and Cyclopropyl Methoxycarbonyl Metomidate. Anesthesia & Analgesia. 122(4). 1008–1014. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guowei Dai Breakdown of academic impact, for papers by Frida Schain Breakdown of academic impact, for papers by Rebecca E. Parker Breakdown of academic impact, for papers by Biqin Tan Breakdown of academic impact, for papers by Debora Valli Breakdown of academic impact, for papers by Yunfeng Shen Breakdown of academic impact, for papers by Feili Chen Breakdown of academic impact, for papers by Andrea Clarke Breakdown of academic impact, for papers by Xiaoming Zou Breakdown of academic impact, for papers by Makoto Hamada
Rankless by CCL
2026